Mindbloom
6 known investors
Mindbloom delivers guided ketamine therapy for depression and anxiety through a technology-enabled platform pairing clinicians with patients. The company serves individuals seeking science-backed mental health treatment in the United States.
Founders & leadership
DB
Dylan BeynonFounder
Investors · 6
In the news
- Mindbloom Faces Wrongful Death Lawsuit Involving At-Home Ketamine Overdose - Behavioral Health Businessbhbusiness.com · 2025
- Sell or Invest in Mindbloom Stock Pre-IPOnasdaqprivatemarket.com · 2025
- Nue Life Health raises $23M Series A Led by Obvious Ventures for psychedelics platformfinance.yahoo.com · 2022
